Page 2 - Chromium Controller News Today

Quarterly Results Earnings per share rose 186.96% over the past year to $0.66, which beat the estimate of $0.50. Revenue of $231,200,000 higher by 34.42% from the same period last year, which missed the estimate of $232,000,000. Guidance 10x Genomics hasnt issued any revenue guidance for the time being. How To Listen To The Conference Call Date: May 13, 2021

In this episode of Industry Focus: Wildcard, Motley Fool Analyst Maria Gallagher joins host Emily Flippen to discuss the prospects for 10x Genomics (NASDAQ:TXG), a healthcare tech company looking to reform the way researchers discover single-cell gene expression.  To catch full episodes of all The Motley Fools free podcasts, check out our podcast center. To get started investing, check out our quick-start guide to investing in stocks. A full transcript follows the video. This video was recor...

Distinct populations of crypt-associated fibroblasts act as signaling hubs to control colon homeostasis Michael David Brügger , Contributed equally to this work with: Michael David Brügger, Tomas Valenta, Hassan Fazilaty Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Software, Visualization, Writing – original draft, Writing – review & editing Affiliation Departmen...